The Theophylline-Erythromydn Interaction
- 1 January 1988
- journal article
- review article
- Published by Taylor & Francis in Journal of Asthma
- Vol. 25 (4), 195-204
- https://doi.org/10.3109/02770908809071366
Abstract
Since its publication in 1976, the original report of an interaction between erythromycin and theophylline by Cummin, Kozak, and Gillman has generated considerable interest and controversy. Many studies with considerably different designs have been performed to address this question. Those studies that most closely simulate the clinical setting suggest that a 7- to 10-day course of concurrent theophylline and erythromycin therapy will result in variable changes in theophylline clearance. It may be that as many as 25% of patients, especially when maintained with serum theophylline concentrations at the upper portion of the therapeutic range, display elevations in serum theophylline concentrations that might lead to clinical symptoms of theophylline toxicity. There has been a suggestion, based on the mean changes in several studies, that the interaction may lead to a 25% increase in serum theophylline concentrations; however, it is clear that there may be a much larger increase in some patients. This toxicity can be anticipated and avoided if careful attention is paid to monitoring the serum theophylline concentrations of such high-risk patients when erythromycin therapy is contemplated as an addition to theophylline therapy. Other macrolide antibiotics may display interactions with theophylline, which may be due in part to the ability of the various antibiotics to form complexes with isoenzymes of the cytochromes P-450. The growing impression of the importance of mycoplasma in asthmatics and the introduction of new macrolides onto the market make the appreciation of this possible interaction of extreme importance to primary care and chest physicians.Keywords
This publication has 32 references indexed in Scilit:
- The interaction between chronic oral slow-release theophylline and single-dose intravenous erythromycinXenobiotica, 1987
- Time‐dependent inhibition of theophylline elimination by erythromycin stearateBiopharmaceutics & Drug Disposition, 1986
- Pharmacokinetic Interactions of the Macrolide AntibioticsClinical Pharmacokinetics, 1985
- Nonlinear Metabolic Disposition of TheophyllineTherapeutic Drug Monitoring, 1984
- Pharmacokinetic Drug Interactions with TheophyllineClinical Pharmacokinetics, 1984
- The Effects of Erythromycin on Theophylline Elimination in Normal MalesThe Journal of Clinical Pharmacology, 1982
- Effect of erythromycin on theophylline kineticsJournal of Allergy and Clinical Immunology, 1981
- Effect of erythromycin on theophylline clearance in asthmatic childrenThe Journal of Pediatrics, 1981
- Relationship of formulation and dosing interval to fluctuation of serum theophylline concentration in children with chronic asthmaThe Journal of Pediatrics, 1981
- Troleandomycin: Effectiveness in steroid-dependent asthma and bronchitisJournal of Allergy and Clinical Immunology, 1974